Stock Scorer

CorMedix Inc. (CRMD)

CorMedix Inc. reported revenue of 101.9M USD for the quarter ending 30 June 2026, up 156.5% from 39.7M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 101.9M +156.5%
Gross Profit Q2 '26 · ending 30 June 2026 77.1M +103.6%
Operating Income Q2 '26 · ending 30 June 2026 42.9M +119.6%
Net Income Q2 '26 · ending 30 June 2026 26M +31.1%
Cost of Revenue Q2 '26 · ending 30 June 2026 14.5M +678.8%
Operating Cash Flow Q2 '26 · ending 30 June 2026 86.2M +187.5%
Free Cash Flow Q2 '26 · ending 30 June 2026 85.7M +185.9%
Shares Outstanding Q2 '26 · ending 30 June 2026 92.5M +34.1%
EPS Q2 '26 · ending 30 June 2026 2.05 +162.8%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 311.7M150.1M163.1M172.8M
20242024-12-31 43.5M-22.4M-17.9M-50.7M
20222022-12-31 65.4K-30.6M-29.7M-24.6M
20212021-12-31 190.9K-29.4M-28.2M-22.6M
20202020-12-31 239.2K-27.2M-22M-22.1M
20192019-12-31 283.3K-21M-16.4M-15.1M
20182018-12-31 429.8K-26.9M-26.8M-23.7M
20172017-12-31 329.3K-32.9M-33M-28.7M
20162016-12-31 224.1K-24.8M-24.6M-22.3M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30101.9M
Q1 '262026-03-31127.4M
Q4 '252025-12-31128.6M
Q3 '252025-09-30104.3M
Q2 '252025-06-3039.7M
Q1 '252025-03-3139.1M
Q4 '242024-12-3131.2M
Q3 '242024-09-3011.5M
Q2 '242024-06-30806.1K
Q4 '222022-12-3129.7K
Q3 '222022-09-306.8K
Q2 '222022-06-3021.3K
Q1 '222022-03-317.6K
Q4 '212021-12-3156.4K
Q3 '212021-09-3038.1K
Q2 '212021-06-308.2K
Q1 '212021-03-3188.3K
Q4 '202020-12-3155.7K
Q3 '202020-09-3093K
Q2 '202020-06-3016.4K

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-3077.1M
Q1 '262026-03-31105.1M
Q4 '252025-12-31107.3M
Q3 '252025-09-3093.1M
Q2 '252025-06-3037.9M
Q1 '252025-03-3137.5M
Q4 '242024-12-3130M
Q3 '242024-09-3010.8M
Q2 '242024-06-30296.3K
Q1 '242024-03-31-818.5K
Q4 '222022-12-3129.3K
Q3 '222022-09-305.3K
Q2 '222022-06-3020.9K
Q1 '222022-03-316.1K
Q4 '212021-12-318.4K
Q3 '212021-09-3012.9K
Q2 '212021-06-30-6.2K
Q1 '212021-03-3126.9K
Q4 '202020-12-31-1.5K
Q3 '202020-09-3013.1K

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-3042.9M
Q1 '262026-03-3163.7M
Q4 '252025-12-3159.1M
Q3 '252025-09-3051.3M
Q2 '252025-06-3019.5M
Q1 '252025-03-3120.1M
Q4 '242024-12-3112.9M
Q3 '242024-09-30-3.3M
Q2 '242024-06-30-15.3M
Q1 '242024-03-31-16.7M
Q4 '232023-12-31-15.7M
Q3 '232023-09-30-10.5M
Q2 '232023-06-30-11.8M
Q1 '232023-03-31-11M
Q4 '222022-12-31-8.4M
Q3 '222022-09-30-7M
Q2 '222022-06-30-8.2M
Q1 '222022-03-31-7M
Q4 '212021-12-31-7.8M
Q3 '212021-09-30-8.6M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-3026M
Q1 '262026-03-3138.6M
Q4 '252025-12-3114M
Q3 '252025-09-30108.6M
Q2 '252025-06-3019.8M
Q1 '252025-03-3120.6M
Q4 '242024-12-3113.5M
Q3 '242024-09-30-2.8M
Q2 '242024-06-30-14.2M
Q1 '242024-03-31-14.5M
Q4 '232023-12-31-14.8M
Q3 '232023-09-30-9.7M
Q2 '232023-06-30-11.3M
Q1 '232023-03-31-10.6M
Q4 '222022-12-31-8.2M
Q3 '222022-09-30-6.9M
Q2 '222022-06-30-7.6M
Q1 '222022-03-31-7M
Q4 '212021-12-31-7.8M
Q3 '212021-09-30-8.6M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-3014.5M
Q1 '262026-03-3112M
Q4 '252025-12-3111.2M
Q3 '252025-09-307.6M
Q2 '252025-06-301.9M
Q1 '252025-03-311.5M
Q4 '242024-12-311.1M
Q3 '242024-09-30634.6K
Q2 '242024-06-30509.8K
Q1 '242024-03-31818.5K
Q4 '222022-12-31406
Q3 '222022-09-301.5K
Q2 '222022-06-30332
Q1 '222022-03-311.5K
Q4 '212021-12-3148K
Q3 '212021-09-3025.2K
Q2 '212021-06-3014.4K
Q1 '212021-03-3161.3K
Q4 '202020-12-3157.2K
Q3 '202020-09-3079.9K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-3086.2M
Q1 '262026-03-3142.4M
Q4 '252025-12-3194.5M
Q3 '252025-09-3030.9M
Q2 '252025-06-3030M
Q1 '252025-03-3119.7M
Q4 '242024-12-31-5.6M
Q3 '242024-09-30-13.6M
Q2 '242024-06-30-14M
Q1 '242024-03-31-17.3M
Q4 '232023-12-31-10.7M
Q3 '232023-09-30-8.7M
Q2 '232023-06-30-8.6M
Q1 '232023-03-31-10.4M
Q4 '222022-12-31-6.2M
Q3 '222022-09-30-6M
Q2 '222022-06-30-5.5M
Q1 '222022-03-31-6.7M
Q4 '212021-12-31-5.9M
Q3 '212021-09-30-5.5M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-3085.7M
Q1 '262026-03-3141.7M
Q4 '252025-12-3192.7M
Q3 '252025-09-3030.4M
Q2 '252025-06-3030M
Q1 '252025-03-3119.7M
Q4 '242024-12-31-5.6M
Q3 '242024-09-30-13.7M
Q2 '242024-06-30-14.1M
Q1 '242024-03-31-17.4M
Q4 '232023-12-31-11M
Q3 '232023-09-30-8.7M
Q2 '232023-06-30-8.6M
Q1 '232023-03-31-10.4M
Q4 '222022-12-31-6.3M
Q3 '222022-09-30-6.1M
Q2 '222022-06-30-5.5M
Q1 '222022-03-31-6.7M
Q4 '212021-12-31-6.5M
Q3 '212021-09-30-6.3M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3092.5M
Q1 '262026-03-3193M
Q3 '252025-09-3086.2M
Q2 '252025-06-3071.9M
Q1 '252025-03-3169M
Q3 '242024-09-3058.8M
Q2 '242024-06-3057.6M
Q1 '242024-03-3157.5M
Q3 '232023-09-3056.6M
Q2 '232023-06-3045.4M
Q1 '232023-03-3144.1M
Q3 '222022-09-3041.2M
Q2 '222022-06-3039.8M
Q1 '222022-03-3138.2M
Q3 '212021-09-3038.1M
Q2 '212021-06-3038.1M
Q1 '212021-03-3136.3M
Q2 '152015-06-3031.6M
Q2 '142014-06-3025.4M
Q2 '132013-06-3013M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-302.05
Q1 '262026-03-312.04
Q4 '252025-12-311.91
Q3 '252025-09-302.09
Q2 '252025-06-300.78
Q1 '252025-03-310.25
Q4 '242024-12-31-0.30
Q3 '242024-09-30-0.81
Q2 '242024-06-30-0.93
Q1 '242024-03-31-0.93
Q4 '232023-12-31-0.92
Q3 '232023-09-30-0.86
Q2 '232023-06-30-0.86
Q1 '232023-03-31-0.80
Q4 '222022-12-31-0.74
Q3 '222022-09-30-0.75
Q2 '222022-06-30-0.80
Q1 '222022-03-31-0.73
Q4 '212021-12-31-0.75
Q3 '212021-09-30-0.73